Methods A cross-sectional study was carried out. Informed consent was obtained from
patients admitted to 20 beds at a Home Care Unit for a 6 month period. Demographic and …

Off-label prescription is part of routine care in palliative medicine, but no information is
available about the situation in Italy. A cross-sectional observational survey was undertaken …

Background Symptomatic control is essential in palliative care, particularly in end-of-life, in
which the pathophysiological changes that characterize this last phase of life strengthen the …

Background: Off-label-use is an indispensable element of palliative medicine. Up to one
third of all drugs are prescribed beyond their licence. It is challenging to find the right …

Background: The 'off-label'use of a drug beyond the specifications of its Marketing
Authorization is widespread in palliative care. It is legal, but there are implications for …

Objective Off-label drug use seems to be integral to adult palliative care pharmacotherapy.
Balancing potential risks and benefits in the context of limited therapeutic options is …

Background: Drug use beyond the licence (off-label use, off-label drug use) is a common
practice in palliative care and respective recommendations can often be identified in the …

Objectives The use of drugs beyond their marketing authorisation, that is, off-label use, is
common practice in palliative care with over 70% of off-label use having little or no scientific …

Context Although off-label medications are frequently prescribed in palliative care, there are
no published studies examining their use in the US Objectives We examined the frequency …

Objective To assess the impact of pharmaceutical care on hospital indicators and clinical
outcomes of palliative care (PC) patients admitted to a secondary hospital. Methods A non …